Advertisment

The Rising Incidence of Gynaecological Cancers in India: Emphasizing Prevention and Early Detection

author-image
Ayanna Amadi
New Update
NULL

The Rising Incidence of Gynaecological Cancers in India: Emphasizing Prevention and Early Detection

Advertisment

The Growing Concern of Gynaecological Cancers

Advertisment

The incidence of gynaecological cancers is on the rise in India, posing a significant health challenge for women. These cancers primarily include cervical, ovarian, and uterine cancers. A report estimates 8,534 new cases of cervical cancer in Tamil Nadu alone in 2023. This escalating number is indicative of the urgency to address the issue at hand and underscores the need for an effective strategy to tackle this burgeoning problem.

The Power of Prevention and Early Detection

Prevention and early detection are crucial in the fight against gynaecological cancers. Regular screenings, such as Pap smears, play a vital role in detecting precancerous changes in the cervix at an early stage. Furthermore, measuring CA 125 levels can aid in the early detection of ovarian cancer. Dr. Ishu Gupta, a senior medical oncologist, has emphasized the importance of widespread HPV vaccination campaigns to reduce the incidence of cervical cancer.

Advertisment

The Role of HPV Vaccination

Human Papillomavirus (HPV) vaccination is a potent preventive measure that can significantly reduce the incidence of cervical cancer. Dr. Ishu Gupta, along with other medical experts, urges women to undergo regular screenings and embrace preventive measures such as HPV vaccination. The World Health Organisation has set targets for screening and vaccination, highlighting their importance in combating this health challenge.

Understanding the Risk Factors

Advertisment

Understanding the risk factors of gynaecological cancers can aid in early detection. These include obesity, hormonal imbalances, and a family history of these cancers. The stigma associated with discussing gynaecological health often leads to delayed diagnosis and treatment, which can result in a more severe disease progression. It is vital for women to take charge of their health and engage in regular screenings and preventive measures.

The Economic Burden of Gynaecological Cancers

A study conducted a pharmacoeconomic analysis comparing the prices of the most expensive and least expensive branded drugs used in the treatment of gynaecological cancer in India. The results indicate a significant cost difference between the costliest and cheapest branded and Jan Aushadhi anticancer drugs and based regimens in treating gynaecological cancer. This cost factor further stresses the importance of prevention and early detection to avoid the financial burden of late-stage treatment.

Moving Forward: Awareness and Healthcare Initiatives

Increased awareness and healthcare initiatives are needed to reduce the burden of gynaecological cancers in India. Women must be educated about the causes, risk factors, symptoms, screening and diagnosis, prevention, and treatment of these cancers. Furthermore, a population-based initiative for the prevention, control, and screening of common Non-Communicable Diseases (NCDs) such as these cancers can play a significant role in reducing their incidence.

Advertisment
Chat with Dr. Medriva !